Latanoprost Cf (Latanoprost)

Latanoprost is a prostaglandin F₂α analogue that binds to FP receptors in the eye. This binding remodels the extracellular matrix of the ciliary body and sclera, increasing uveoscleral outflow of aqueous humor, which in turn lowers intraocular pressure.

The dosing regimen for Latanoprost Cf is determined by the prescribing ophthalmologist. In clinical practice the medication is typically instilled as one drop in the affected eye(s) once daily, usually in the evening, but the exact schedule should follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Latanoprost Cf. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally provides greater intraocular pressure reduction than beta‑blockers such as timolol. It is administered once daily, has a favorable dosing convenience, and is often used as first‑line therapy, whereas other classes may require multiple daily doses or have different side‑effect profiles.

Latanoprost should be stored at room temperature, below 25 °C, in its original bottle. Keep the container tightly closed, protect it from light and moisture, and avoid freezing. Do not use the product if the solution appears discolored or contains particles.

The medication is applied as a single drop into the conjunctival sac of the affected eye(s) at the same time each day, preferably in the evening. The dropper tip should not touch the eye or any other surface to maintain sterility.

Serious adverse events, although rare, include severe eye inflammation such as uveitis or iritis, allergic reactions with swelling or rash around the eye, and corneal edema that can impair vision. Any of these symptoms require immediate medical evaluation.

Patients with known hypersensitivity to latanoprost or any component of the formulation should avoid its use. It is also contraindicated in eyes with active infections, severe inflammation, or in individuals who have had a recent ocular surgery until cleared by their ophthalmologist.